Sfoglia per Autore
Absence of clinical, virological, and immunological signs of progression in HIV-1-infected patients receiving active anti-interferon-alpha immunization: a 30-month follow-up report
1996 A. Gringeri, E. Santagostino, M. Cusini, M. Perja, A. Marinoni, P.M. Mannucci, A. Burny, M. Criscuolo, W. Lu, J.M. Andrieru, J.P. Mbika, A. Lachgar, L.S. Fall, V. Chams, M. Feldman, P. Hermans, J.F. Zagury, B. Bizzini, M. Musicco, D. Zagury
Safety and immunogenicity of HIV-1 Tat toxoid in immunocompromised HIV-1-infected patients
1998 A. Gringeri, E. Santagostino, M. Perja, P.M. Mannucci, J.F. Zagury, B. Bizzini, A. Lachgar, M. Carcagno, J. Rappaport, M. Criscuolo, W. Blattner, A. Burny, R.C. Gallo, D. Zagury
High prevalence of serum cryoglobulins in multitransfused hemophilic patients with chronic hepatitis C
1998 E. Santagostino, M. Colombo, D. Cultraro, M. Perja, A. Gringeri, P.M. Mannucci
A prospective clinical trial of implantable central venous access in children with haemophilia
1998 E. Santagostino, A. Gringeri, M. Perja, P.M. Mannucci
A prophylactic and therapeutic AIDS vaccine containing as a component the innocuous Tat toxoid
1998 H. Le Buanec, A. Lachgar, B. Bizzini, J.F. Zagury, J. Rappaport, E. Santagostino, M. Perja, A. Gringeri
Anti-IFN alpha immunization raises the IFN alpha-neutralizing capacity of serum--an adjuvant to antiretroviral tritherapy
1999 D. Zagury, H. Lecoq, I. Gervi, H. Le Buanec, J. F. Zagury, B. Bizzini, A. Burny, P. Hermans, M. Perja, E. Santagostino, A. Gringeri
Tat toxoid as a component of a preventive vaccine in seronegative subjects
1999 A. Gringeri, E. Santagostino, M. Perja, H. Le Buanec, B. Bizzini, A. Lachgar, J. F. Zagury, J. Rappaport, A. Burny, R. C. Gallo, D. Zagury
Identification of immunodominant epitopes in inactivated Tat-vaccinated healthy and HIV-1-infected volunteers
2003 D. M. Noonan, A. Gringeri, R. Meazza, O. Rosso, S. Mazza, M. Perja, H. Le Buanec, R. S. Accolla, A. Albini, S. Ferrini
Long-term safety and feasibility of arteriovenous fistulae as vascular accesses in children with haemophilia : a prospective study
2003 E. Santagostino, A. Gringeri, L. Berardinelli, C. Beretta, M. Perja, P. M. Mannucci
Prospective cost-effectiveness study of regular continuous prophylactic replacement therapy in adults with severe hemophilia A
2008 A. Gringeri, M.S. Monzini, S. von Mackensen, M. Muça-Perja, F. Borghetti, L. Mantovani
Sequential combined bypassing therapy : a rescue option in refractory bleeds – the Italian experience
2008 A. Gringeri, E. Santagostino, M.E. Mancuso, A. Meloni, M. Muça-Perja, S.M. Siboni
Pharmacotherapy of haemophilia A
2011 A. Gringeri, M. Perja, L. Mangiafico, S. von Mackensen
Safety and effectiveness of raltegravir in patients with haemophilia and anti-HIV multidrug resistance
2012 L. Mangiafico, M. Perja, F. Fusco, S. Riva, D. Mago, A. Gringeri
Ultrasonography of haemophilic arthropathy
2012 M. Perja, S. Riva, B. Grochowska, L. Mangiafico, D. Mago, A. Gringeri
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile